Stephen K Frankel

Summary

Publications

  1. ncbi The pulmonary vasculitides
    Stephen K Frankel
    National Jewish Health, Denver, CO 80206, USA
    Clin Chest Med 31:519-36. 2010
  2. ncbi Update in idiopathic pulmonary fibrosis
    Stephen K Frankel
    Division of Pulmonary Sciences and Critical Care Medicine, University of Colorado Denver, Denver, Colorado, USA
    Curr Opin Pulm Med 15:463-9. 2009
  3. ncbi A detailed evaluation of acute respiratory decline in patients with fibrotic lung disease: aetiology and outcomes
    Tristan J Huie
    University of Colorado Denver, Division of Pulmonary Sciences and Critical Care Medicine, Aurora, Colorado 80045, USA
    Respirology 15:909-17. 2010
  4. ncbi Anti-synthetase syndrome in ANA and anti-Jo-1 negative patients presenting with idiopathic interstitial pneumonia
    Aryeh Fischer
    National Jewish Health, Interstitial and Autoimmune Lung Disease Program, Denver, CO 80206, United States
    Respir Med 103:1719-24. 2009
  5. ncbi Increased cell surface Fas expression is necessary and sufficient to sensitize lung fibroblasts to Fas ligation-induced apoptosis: implications for fibroblast accumulation in idiopathic pulmonary fibrosis
    Murry W Wynes
    Program in Cell Biology, Department of Pediatrics, National Jewish Health, Denver, CO 80206, USA
    J Immunol 187:527-37. 2011
  6. ncbi Acute exacerbations of fibrotic hypersensitivity pneumonitis: a case series
    Amy L Olson
    Division of Pulmonary Sciences and Critical Care Medicine, University of Colorado Health Sciences Center, 4200 East Ninth Ave, C272, Denver, CO 80262, USA
    Chest 134:844-50. 2008
  7. ncbi Compartmentalized expression of c-FLIP in lung tissues of patients with idiopathic pulmonary fibrosis
    Seung Ick Cha
    Program in Cell Biology, Department of Pediatrics, National Jewish Health, Denver, CO 80206, USA
    Am J Respir Cell Mol Biol 42:140-8. 2010
  8. ncbi Heart rate recovery after 6-min walk test predicts survival in patients with idiopathic pulmonary fibrosis
    Jeffrey J Swigris
    Interstitial Lung Disease Program and Autoimmune Lung Center, National Jewish Medical and Research Center, Denver, CO 80206, USA
    Chest 136:841-8. 2009
  9. ncbi Challenges in pulmonary fibrosis. 3: Cystic lung disease
    Gregory P Cosgrove
    National Jewish Medical and Research Center, 1400 Jackson Street, F107, Denver, Colorado 80206, USA
    Thorax 62:820-29. 2007
  10. ncbi Eosinophilic lung diseases
    Evans R Fernandez Perez
    Interstitial Lung Disease Program, Autoimmune Lung Center, National Jewish Health, Denver, CO 80206, USA
    Med Clin North Am 95:1163-87. 2011

Collaborators

Detail Information

Publications12

  1. ncbi The pulmonary vasculitides
    Stephen K Frankel
    National Jewish Health, Denver, CO 80206, USA
    Clin Chest Med 31:519-36. 2010
    ....
  2. ncbi Update in idiopathic pulmonary fibrosis
    Stephen K Frankel
    Division of Pulmonary Sciences and Critical Care Medicine, University of Colorado Denver, Denver, Colorado, USA
    Curr Opin Pulm Med 15:463-9. 2009
    ..This review aims to highlight and place in context recent advances in and insights into the natural history, diagnosis, and management of idiopathic pulmonary fibrosis (IPF)...
  3. ncbi A detailed evaluation of acute respiratory decline in patients with fibrotic lung disease: aetiology and outcomes
    Tristan J Huie
    University of Colorado Denver, Division of Pulmonary Sciences and Critical Care Medicine, Aurora, Colorado 80045, USA
    Respirology 15:909-17. 2010
    ..A comprehensive diagnostic evaluation is recommended for all patients with fibrotic lung disease and acute respiratory decompensation. However, the effect on clinical outcomes of this evaluation remains unknown...
  4. ncbi Anti-synthetase syndrome in ANA and anti-Jo-1 negative patients presenting with idiopathic interstitial pneumonia
    Aryeh Fischer
    National Jewish Health, Interstitial and Autoimmune Lung Disease Program, Denver, CO 80206, United States
    Respir Med 103:1719-24. 2009
    ..To describe the clinical features of patients presenting with "idiopathic" interstitial pneumonia that were diagnosed with anti-synthetase syndrome based on clinical features and positive anti-PL-7 or PL-12 antibodies...
  5. ncbi Increased cell surface Fas expression is necessary and sufficient to sensitize lung fibroblasts to Fas ligation-induced apoptosis: implications for fibroblast accumulation in idiopathic pulmonary fibrosis
    Murry W Wynes
    Program in Cell Biology, Department of Pediatrics, National Jewish Health, Denver, CO 80206, USA
    J Immunol 187:527-37. 2011
    ..Our findings also suggest that approaches aimed at increasing Fas expression by lung fibroblasts and myofibroblasts may be therapeutically relevant in IPF...
  6. ncbi Acute exacerbations of fibrotic hypersensitivity pneumonitis: a case series
    Amy L Olson
    Division of Pulmonary Sciences and Critical Care Medicine, University of Colorado Health Sciences Center, 4200 East Ninth Ave, C272, Denver, CO 80262, USA
    Chest 134:844-50. 2008
    ..While best described in patients with IPF, they have also been reported in patients with other forms of interstitial lung disease. We sought to determine if this same phenomenon occurs in patients with hypersensitivity pneumonitis (HP)...
  7. ncbi Compartmentalized expression of c-FLIP in lung tissues of patients with idiopathic pulmonary fibrosis
    Seung Ick Cha
    Program in Cell Biology, Department of Pediatrics, National Jewish Health, Denver, CO 80206, USA
    Am J Respir Cell Mol Biol 42:140-8. 2010
    ....
  8. ncbi Heart rate recovery after 6-min walk test predicts survival in patients with idiopathic pulmonary fibrosis
    Jeffrey J Swigris
    Interstitial Lung Disease Program and Autoimmune Lung Center, National Jewish Medical and Research Center, Denver, CO 80206, USA
    Chest 136:841-8. 2009
    ....
  9. ncbi Challenges in pulmonary fibrosis. 3: Cystic lung disease
    Gregory P Cosgrove
    National Jewish Medical and Research Center, 1400 Jackson Street, F107, Denver, Colorado 80206, USA
    Thorax 62:820-29. 2007
    ....
  10. ncbi Eosinophilic lung diseases
    Evans R Fernandez Perez
    Interstitial Lung Disease Program, Autoimmune Lung Center, National Jewish Health, Denver, CO 80206, USA
    Med Clin North Am 95:1163-87. 2011
    ..This review focuses on the clinical features, general diagnostic workup, and management of the eosinophilic lung diseases...
  11. ncbi A rare presentation of ischemic pseudomembranous colitis due to Escherichia coli O157:H7
    Jessica B Kendrick
    Department of Medicine, University of Colorado Denver and Health Sciences Center, Denver, CO, USA
    Clin Infect Dis 45:217-9. 2007
    ..Herein, we report a sporadic case of ischemic E. coli Ol57:H7 pseudomembranous colitis in an adult that occurred during a national outbreak of E. coli Ol57:H7 in the United States...
  12. ncbi Pericardial abnormalities predict the presence of echocardiographically defined pulmonary arterial hypertension in systemic sclerosis-related interstitial lung disease
    Aryeh Fischer
    Division of Rheumatology, National Jewish Medical and Research Center, 1400 Jackson St, Denver, CO 80206
    Chest 131:988-92. 2007
    ..To determine the prevalence and significance of pericardial abnormalities in systemic sclerosis (SSc)-related interstitial lung disease (ILD)...